Key facts
- This page summarizes Sharon E. Underberg's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 May 2023, 17:04.
Sharon E. Underberg - 05 May 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- EVP, GC & Corporate Secretary
- Issuer ticker
- IDXX
- Reported as of
- 05 May 2023
- Net transaction value
- +$99,952
- SEC form
- 4
- Accepted by SEC
- 08 May 2023, 17:04:40 UTC
- Prior SEC filing
- 16 Feb 2023
- Next SEC filing
- 16 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sharon E. Underberg filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 08 May 2023.
Change
- Previous filing in this sequence was filed on 16 Feb 2023.
- Current net transaction value: +$99,952.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $99,952
- Shares
- +483
- Change %
- +13%
- Price
- $206.94
- Shares after
- 4,245
- Date
- 05 May 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Common Stock
Options Exercise
- Transaction value
- Shares
- -483
- Change %
- -50%
- Price
- Shares after
- 483
- Date
- 05 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 483
- Exercise price
- $206.92
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes 14.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023.
Footnote F2
Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.
Footnote F3
Not applicable.